Century Therapeutics
Price & Volume
Stats
See moreOpen | $2 |
Previous Close | $2.05 |
Day Range | $1.98-$2.03 |
52W Range | $0.43-$3.04 |
Market Cap | $371.2M |
Shares Short | 29M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$78.9M |
Diluted EPS | -$0.93 |
News
See moreYahoo Finance • 20 days ago
Century Therapeutics GAAP EPS of -$0.17 misses by $0.05
Yahoo Finance • 2 months ago
Century Therapeutics (IPSC) to Present CNTY-813 Data at Scientific Congresses
Yahoo Finance • 2 months ago
Cutaneous Lupus Erythematosus Market to Expand at a CAGR of 8% During the Forecast Period (2026–2036) Amid Emerging Therapies and Increasing Healthcare Investments | DelveInsight
Yahoo Finance • 3 months ago
Quant rating check: Top oncology peers as Nuvalent goes private in $10.6B deal with GSK
About
CEO | Dr. Brent Pfeiffenberger M.B.A., Pharm.D. |
Address | 25 North 38th Street, Philadelphia, PA, United States, 19104 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 78 |